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 Short Abstract (219 words) 
 
Background: Publicly available data show variation in GPs use of urgent suspected cancer 
referral pathways. We investigated if this could be due to small numbers of cancer cases and 
random case-mix, rather than true variation in performance. 
 
Methods: We analysed individual practice urgent suspected cancer referral (USC) detection 
(number of practice’s cancer detected via USC) and conversion rates (number of practice’s 
USC referrals which are cancer) in routinely collected data on cancer referrals from GP 
practices in all of England (over four years) and North-east Scotland (over seven years). We 
explored the effect of pooling data. We then modelled the effects of adding random case-mix 
to practice variation. 
 
Results: Correlations between practice detection rate and conversion rate became less 
positive when data were aggregated over several years. Adding random case-mix to between-
practice variation indicated that the median proportion of poorly performing practices 
correctly identified after 25 cancer cases were examined was 20% (IQR 17 to 24) and after 
100 cases was 44% (IQR 40 to 47).     
 
Conclusion: Much apparent variation in GPs’ use of suspected cancer referral pathways can 
be attributed to random case-mix. The methods currently used to assess the quality of GP 
suspected cancer referral performance, and to compare individual practices, are misleading. 
These should no longer be used and more appropriate and robust methods should be 
developed.  
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 Abstract (300 words) 
 
Objective:  
Publicly available data are reported as showing unacceptable variation in GPs use of urgent 
suspected cancer referral pathways. We investigated how much of this variation in 
performance is due to small numbers of cancer cases and random case-mix of cancer 
presentations. 
Design:  
Analysis of routinely collected data on cancer referrals from GP practices and modelling of 
the effects of adding random case-mix to practice variation. Examination of detection rate 
(proportion of cancers referred by the urgent pathway) and conversion rate (proportion of 
urgent pathway referrals diagnosed with cancer).  
Setting:  
955,502 cancer cases from 8,303 practices in NHS England over four years; 10,615 cancer 
cases from 77 practices in NHS Grampian, Scotland over seven years. Modelling conducted 
with simulated practices having between 25 and 200 cancer cases. 
Results:  
Correlations between practice detection rate and conversion rate were weaker when data were 
aggregated over several years compared to within individual years: NHS England aggregated 
0.12 (95% confidence interval 0.09 to 0.14), individual years between 0.24 (0.21 to 0.26) and 
0.26 (0.23 to 0.28), NHS Grampian aggregated -0.22 (-0.41 to 0.08), individual years 
between 0.08 (-0.25 to 0.35) and 0.28 (0.08 to 0.53); Year to year correlation was weaker for 
detection rate, between 0.20 (0.17 to 0.22) and 0.26 (0.23 to 0.29), than for conversion rate, 
between 0.53 (0.51 to 0.55) and 0.55 (0.53 to 0.57), implying detection rate is less consistent 
over time. Adding random case-mix to simulated between-practice variation resulted in the 
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 median proportion of poorly performing practices correctly identified after 25 cancer cases 
were examined being 20% (IQR 17 to 24) and after 100 cases 44% (40 to 47). 
Conclusions: Much apparent variation in general practitioners’ use of suspected cancer 
referral pathways can be attributed to random case-mix. Measures from single years of data 
are misleading and should not be publically reported.   
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 INTRODUCTION 
Early detection and treatment of cancer is an important goal for health services. The United 
Kingdom (UK) and other countries with strong primary care gatekeeper systems persistently 
display lower cancer survival rates when compared to other developed countries. This effect 
is widely attributed to longer intervals in the cancer diagnostic and treatment pathway 
[Coleman et al, 2011; Richards et al, 2009]. 
 
The UK NHS has existing fast-track urgent suspected cancer (USC) referral pathways from 
primary to secondary care [NICE, 2007; Scottish Government, 2009]. In England patients 
referred from primary care with suspected cancer should be seen in secondary care within 
two weeks (hence the common term “2 week wait referrals”) [Meechan et al, 2012]. 
Department of Health, 2000] and begin treatment within 62 days (England and Scotland) 
[Department of Health 2000; Scottish Executive Health Department, 2007].  
 
There is evidence that practices vary in the frequency with which they make USC referrals. In 
Scotland, an analysis of 18,775 USC referrals in 2008 reported a six-fold variation in use of 
this referral route [Baughan et al, 2011]. Similar variation was shown in an analysis of 
865,494 referrals in England over one year [Meechan et al, 2012]. This latter analysis also 
found a positive correlation between practices’ detection rate (the proportion of all cancers 
referred as USC) and conversion rate (the proportion of all USC referrals resulting in a cancer 
diagnosis). This correlation has been used as evidence of a quality gradient: with “high 
quality” practices being both more accurate (higher detection rate) and more efficient (higher 
conversion rate) in their use of USC than others [Meechan et al, 2012]. In England, the 
National Cancer Intelligence Network now publishes GP practice profiles for cancer that 
include annual detection and conversion rates [NCIN, 2014]. This has led to media reports of 
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 unacceptable variations in GP performance culminating in the recent recommendation by the 
UK Health Secretary that “poorly performing” practices be publicly named. [BBC Website, 
2012; BBC Website 2014]. 
 
Current reporting is based on referral data from a single year and does not distinguish 
between different cancer types. New cases of cancer are relatively uncommon in primary 
care, so the number of cases in any year will be small. Furthermore, cancer in primary care is 
heterogeneous: some cancers typically present with features amenable to prompt recognition 
and referral (e.g. testicular cancer presenting as a lump) while others typically have non-
specific symptoms (e.g. ovarian cancer) [Bottle et al, 2012]. This is reflected in substantial 
differences in the use of the USC pathway according to cancer type [NCIN, 2014] Even 
within the same cancer type, some presentations will prompt urgent referral (e.g. lung cancer 
presenting with haemoptysis) while others may not (e.g. lung cancer presenting with non-
specific symptoms) [Birring et al, 2005]. Furthermore pre-symptomatic cancers which had 
been detected via national screening programmes are currently counted in the non-USC 
category, introducing a further source of variation in apparent GP performance.  
 
Current national guidelines dictate which circumstances warrant USC referral, so adherence 
to these will inevitably influence which referral route GPs choose. Thus, depending on case-
mix, two practices following guidelines equally well may have different detection and 
conversion rates with the appearance, based on current metrics, that one is better than the 
other [Dua et al, 2009].  
 
The aim of our study was to investigate the effect of the number of cancer cases and random 
case-mix on the variation in GP performance in cancer diagnosis and their implication for 
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 public reporting. First, we examined the effect of aggregating data for each practice over 
several years on the proposed “quality gradient” indicated by the association between 
detection and conversion rates. Second, we examined year to year correlation in detection and 
conversion rates in order to assess whether practices were consistent over time in their 
reported rates. Finally, we carried out a simulation modelling study to estimate the variation 
in USC rates attributable to random case-mix and used this to estimate the likelihood that a 
poorly performing practice would be correctly identified.  
 
METHODS 
Data sources 
The current study used two databases. The first provided data on route of cancer diagnosis, 
including USC referral from primary care over seven years (2006-12) in the NHS Grampian 
region of Northeast Scotland. The second contained data on route of cancer diagnosis 
including two-week referrals over four years (2010-2013) from NHS England. USC in 
Scotland and two-week referrals in England are the broadly equivalent referral routes by 
which GPs in Scotland and England respectively secure an urgent secondary care 
appointment for patients in whom a strong suspicion of cancer is supported by existing 
guidelines.  
 
The data from Northeast Scotland comprised practice level data for all GP practices in the 
NHS Grampian region relating to all cancer diagnoses and all USC referrals made between 
02 January 2006 and 30 November 2012. These were obtained from the NHS Grampian 
Cancer Care Pathway database (CCPd). The CCPd is a detailed clinical database maintained 
by NHS Grampian recording information about all cancer referrals made by GPs within the 
region, as well as information about all cancer diagnoses, irrespective of route of diagnosis. 
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 The start date for this data represents the earliest date of collection of USC referral data. The 
NHS England data comprised publicly available practice level data for all GP practices on the 
NCIN website [NCIN, 2014] for the years 2010-2013 inclusive. 
 
Data processing and analysis  
With the NHS Grampian data, for each practice and year we extracted the total number of 
cancers, the number of cancers detected after USC referral and the total number of USC 
referrals. We also used demographic data from each practice to calculate age-sex 
standardised referral ratios based on the number of USC referrals that would have been 
expected from the practice relative to other practices in NHS Grampian. With the NHS 
England data, for each practice and year we extracted the total number of cancers treated, the 
number of cancers detected after USC referral and the total number of USC referrals. We also 
extracted the age-sex standardised referral rate. 
 
With both extracted datasets, we calculated the detection rate and conversion rate for each 
practice for each year and aggregated across years. These are analogous to the sensitivity and 
positive predictive value respectively of a diagnostic test: in this case the “diagnostic test” is 
the practice GPs’ decisions to refer patients via the USC route. We used these measures 
because they have been promoted for comparison between practices and are currently being 
made publically available [Meechan et al, 2012; NCIN, 2014].  
 
In both databases, we found that some practices had only a small number of cancer cases. For 
the NHS Grampian dataset, data from practice-years which contained no cancers diagnosed 
via the USC pathway, were included in the analysis of aggregated practice data but excluded 
from investigation of detection and conversion rates. In the NHS England data, where there 
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 were less than six cancers referred or diagnosed in a year for a practice, the exact number was 
not published, so the corresponding record from that year was excluded from all analyses.  
 
For each individual practice-year and for practice data aggregated across all years, we plotted  
detection and conversion rates as scatter plots, with lines fitted by linear and local polynomial 
regression, and calculated the correlation coefficient between detection and conversion rates. 
This followed the method previously used on single year data [Meechan et al, 2012] and used 
the Spearman rank correlation coefficient with bootstrapped confidence intervals method for 
both datasets. We calculated the mean (SD) of detection and conversion rates for aggregate 
data from all practices and by three different case volumes of cancer diagnosis over the study 
periods (1-75 cases, 76-150, and 151-400). 
 
Year to year correlation 
We calculated the year to year correlation of practice detection and conversion rates, using 
the Spearman rank correlation coefficient, for all pairs of adjacent years. To examine the 
effects of number of cancers on these correlations, we analysed this by subgroups of practices 
according to the number of new cancer cases in one year.  
 
Simulation modelling 
In order to examine the effect of random case-mix at practices of different sizes, we 
generated sets of simulated GP “practices”. Within each set, we introduced three sources of 
variation in measured performance: true practice variation, random case-mix and practice 
case numbers.  
 
These were introduced as follows:  
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  True Practice Variation 
This represents between-practice variation in performance, such as would result from 
differences in competence, population or organisation. It was introduced by randomly 
allocating each practice its own Practice Detection Rate, taken from a normal distribution 
with the mean set at the overall mean detection rate from the NCIN data (0.477). The 
standard deviation for this distribution was set to one of three arbitrary values chosen to 
represent low, moderate and high true practice variation (0.025, 0.05 and 0.075 respectively).   
 
Practice case numbers 
This was introduced to examine the effect of different numbers of cancer cases on reported 
variation. We set practice case numbers at values of 25, 50, 75, 100, 150 and 200 cases. For 
reference, an average sized practice with approximately 6000 patients can expect around 25 
new cancers in a year.  
 
Random casemix 
This represents within-practice variation in performance resulting from the characteristics of 
individual cancer cases. It assumes that the difficulty in diagnosis lies in each case, such that 
two equally performing doctors, following guidelines, would vary in observed performance 
according to the cases they saw. It was introduced by having practices randomly sample their 
specified number of “cases” from a larger pool of cases. Cases in this larger pool were all 
allocated a “referral route” property in advance (either USC or other), with the proportion of 
USC cases set at the Practice Detection Rate. As a result, the observed detection rate for each 
“practice” represented a single sampling from a binomial distribution whose probability 
parameter was sampled from a Gaussian distribution. 
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 Modelling procedure 
We created 18 model specifications (3 levels of between-practice variation x 6 practice case 
numbers).  Each specification of the model was constructed for sets of 1000 practices and run 
200 times. Within each specification, we recorded the minimum, maximum, mean and 
standard deviation of the detection rate within each run. We then summarised them by 
calculating the medians of these measures over all the runs. 
 
 Within each specification, we designated “practices” whose Practice Detection Rate was in 
the lowest decile of the distribution as poorly performing. After adding the effects of random 
case-mix, we recorded the number of these which were correctly identified as poorly 
performing (still in the lowest decile of the distribution). We also recorded the number of 
practices which were incorrectly identified as poorly performing (ie Practice Detection Rate 
outside the lowest decile before introducing case-mix, but in the lowest decile afterwards). 
For both these measures, we reported the median and interquartile range across all of the runs 
for each model specification.  
 
Comparison with published data 
We compared the standard deviations seen in each of the model specifications with the data 
from both NHS Grampian  and NHS England for comparable cancer case numbers 
(expressed as a range either side of the model specification number). Statistical analyses and 
modelling were conducted using SPSS for Windows Version 20 and R version 3.02. 
 
RESULTS 
NHS Grampian data included 25,278 USC referrals and 10,615 cancers from 77 practices 
over a seven year period. When practice-years with no cancers diagnosed via the USC 
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 pathway in the NHS Grampian dataset were excluded there were 24,934 USC referrals and 
9,945 cancers. NHS England data included 4,158,358 USC referrals and 955,502 cancers 
from 8,303 practices over a four year period.  When incomplete data (from practice-years 
with <6 recorded cancer cases referred by USC) were excluded from the NHS England data 
there were 3,808,406 USC referrals and 881,078 cancers remaining from 6,735 practices. 
Characteristics of the included practices, including are shown in table 1. The NHS Grampian 
dataset included a higher proportion of very small practices (list size <3000) than in England 
(20.8% vs 9.3%). The mean (SD) practice detection and conversion rates for data aggregated 
over seven years in NHS Grampian were 0.38 (0.10) and 0.18 (0.06) respectively; for NHS 
England over four years they were 0.48 (0.09) and 0.12 (0.06). 
Table 2 shows that overall, 4,003 (37.7%) of cancers in the NHS Grampian dataset were 
referred by the USC pathway. The detection rate was particularly low in 2006-8, this finding 
appears to reflect unfamiliarity with implementation of the USC referrals system as more 
than half of cancers diagnosed after urgent referral went through generic urgent pathways as 
opposed to cancer specific ones (data available on request). From 2009 onwards, 3,435 out of 
6,639 (51.6%) of cancers in NHS Grampian were referred by the USC pathway. In the NHS 
England dataset 413,718 out of 881,080 (47.0%) of cancers were referred by the USC 
pathway.  
Correlation coefficients between practice detection rates and conversion rates for individual 
years ranged from 0.08 (95% confidence interval -0.25 to 0.35) and 0.28 (0.08 to 0.53) in 
NHS Grampian and between 0.24 (0.21 to 0.26) and 0.26 (0.23 to 0.28) in NHS England as 
shown in Table 3. When practice data over several years were aggregated the correlation was 
weakened in both datasets: 2006-12 in NHS Grampian -0.22 (-0.41 to 0.08) and in NHS 
England 0.12 (0.09 to 0.14). Limiting the NHS Grampian data to cancers diagnosed from 
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 2009 onwards had little effect on the pooled correlation: -0.16 (-0.34 to 0.01). The 
relationship between detection rates and conversion rates is shown graphically in Figure 1 for 
years common to both datasets and for aggregated data. However, the positive correlations 
between detection rates and conversion rates in individual years may be spurious. Both 
detection rate and conversion rate feature the number of cancers diagnosed via the USC 
pathway as both the numerator and part of the denominator.  Consequently, in a practice-year 
with a high proportion of “clinically obvious” cancers i.e. clinical presentations which clearly 
meet criteria for USC referral, both detection rate and conversion rate will be relatively high. 
Conversely, when the proportion of clinically obvious cancers is low, both detection rate and 
conversion rate will be low. This may lead to a spurious correlation between detection rate 
and conversion rate which is more likely to occur with small sample sizes and/or substantial 
case-mix. When numbers of cancers are pooled this spurious correlation will be diminished.   
In the NHS England data, there was a clear difference between detection rates and conversion 
rates in their year to year correlations. For practice detection rates, practice pooled 
correlations between pairs of consecutive years were weak:  between 0.20 (95% confidence 
interval 0.17 to 0.22) and 0.26 (0.23 to 0.29) suggesting practice detection rates were not 
consistent from year to year. In contrast, year to year correlations for practice pooled 
conversion rate were moderately strong, between 0.53 (0.51 to 0.55) and 0.55 (0.53 to 0.57), 
suggesting greater consistency from year to year. Table 4 shows the results of this analysis 
with practices sub-grouped according to their number of cases. Similar year to year analysis 
on NHS Grampian data was limited by quite small numbers after excluding practices with no 
cancers in one or other year, so confidence intervals were wide (Table 4).  
The simulation modelling of detection rates is reported in Table 5. The first column indicates 
whether the model specification included low, medium or high between-practice variation.  
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 The observed standard deviations in the third column are consistently larger than the standard 
deviations used to simulate true practice variation, indicating that case-mix increases the 
observed variance. Unsurprisingly this difference is greater when the number of cases is 
small. The implications of this increase in variance due to case-mix are shown in the columns 
of Table 4 relating to “poor performing practices”. The first pair show number of practices in 
the simulations (median with interquartile range) which were specified as poorly performing 
before the addition of case mix and were subsequently detected after the introduction of case-
mix variation. The second pair of columns shows the total number of practices which were in 
the lowest decile for detection rate after introducing random case-mix. .  
Comparison of the pattern of standard deviations for different levels of between-practice 
variation (Table 5) with the standard deviations for practices whose aggregate number of 
cancers was (25-75), medium (76-150) or large (151-400) from the empirical data in Table 1 
suggests that the model with moderate between-practice variation is most closely matched to 
the actual data from both empirical datasets..   The implication of this is that with 25 cancer 
cases per practice, only a median of 20% (IQR 17 to 24) poorly performing practices will be 
correctly identified and most practices identified as poorly performing will be incorrectly 
labelled. As the number of cases per practice rises, the accuracy of prediction increases, but 
only slowly and incompletely: with 100 cases the probability of a poorly performing practice 
being correctly identified is 44 % (95% CI 40 to 47); and with 200 cases, 57% (54 to 59).  
 
DISCUSSION 
This is the first study to examine the effects of number of cases and random case-mix on a 
publicly reported measure of GP practices’ performance in the use of urgent suspected cancer 
pathways. The results indicate that differences between practices, and apparent quality 
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 gradients, seen within individual years are weakened when data are aggregated over several 
years suggesting that case-mix – different cancers with different referral pathways - rather 
than actual clinical performance, accounts for much of the observed variation. The modelling 
exercise suggests that at least 100 cancer cases per practice are necessary before the 
probability is close to 50% that an observed poorly performing practice is actually poorly 
performing. In terms of an average-sized UK practice it would take approximately four years 
for this number of cancer cases to accrue.  
 
Our choice of two databases allows for both the extra detail and duration of the Northeast 
Scotland dataset and the breadth and generalisability of the NHS England dataset. The fact 
that broadly comparable results emerged strengthens our findings and adds credence to the 
belief that, in both datasets the validity and accuracy of cancer cases and referrals routes are 
acceptable. While the Scottish and English datasets were broadly similar they were not 
identical in their definitions nor in the time of the study in relation to introduction of specific 
cancer referral pathways. Furthermore, the Scottish data were from one region only, whereas 
the English data were from the whole country. This precludes making comparisons between 
the datasets, and instead, the analysis focuses on within-dataset comparisons showing that 
similar findings appear in both. Both datasets had limitations when it came to small numbers 
of cancer cases, in the NHS England database data from practices with less than six USC 
referrals in one year were not available. We did not attempt to impute these data. In addition, 
we did not attempt to address other possible sources of practice variation such as differences 
in practice population rather than GP performance. Within the Scottish data, there were some 
single doctor practices with very small list sizes, meaning that it was possible they would 
have a year when no cancers were diagnosed. These null data were excluded from the 
analysis since a meaningful detection rate could not be calculated. However, as our data 
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 suggest relatively modest variation in GP performance after adjusting for random case-mix, 
any adjustment for practice characteristics would be likely to further reduce the variation in 
intrinsic GP performance.  
 
We deliberately followed previously reported methods for comparing single year inter-
practice variation in the use of USC referrals as these measures are currently used in routine 
reporting and public feedback [Meechan et al, 2012]. This is despite the fact that the method 
has an obvious limitation in that detection and conversion rates are not a naturally 
complementary pair of measures. One unexpected advantage of this pairing however, is that 
unlike sensitivity and specificity, the relationship between these two measures is not 
influenced by prevalence. Our finding that the correlation between detection and conversion 
rates was diminished (or reversed) by aggregating data over several years suggests that 
correlations based on small case numbers may be largely spurious. In our modelling, we 
focused on the detection rate as this was the measure highlighted by media and politicians, 
and also because this showed more year on year variation than the conversion rate. It is not 
the only measure of diagnostic quality, however, and further work may need to examine 
conversion rate or other approaches such as imputing specificity. 
 
Our modelling exercise was based on empirical data from NHS England with the detection 
rate set according to this. It was designed to use sample sizes which are representative of 
routine practice. With an annual cancer incidence of around 4.3/1000 per annum, a small 
practice of 3000 patients can expect only around 13 new cancer cases each year, and will 
need eight years to accumulate approximately 100 cases. A medium sized practice of 6000 
patients (close to the UK average) will need four years. Only a very large practice of around 
24,000 patients is likely to record 100 cancer cases in a year. Even with 100 cases, our 
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 modelling data indicate that the probability of a statistically outlying practice being an 
intrinsically poor performer is still only around 50%. At present, most practices identified as 
poorly performing from annual data will be wrongly labelled, and most poorly performing 
practices will not be detected.  
 
Individual case presentations of cancer vary and this study highlights the need to consider 
number of cases and case-mix variation in evaluating the performance of GP practices in their 
use of USC referral. Simply reporting values for detection and conversion rates on annual 
data, and considering all cancers together, has the clear potential to mislead both practices 
and the public. Allied concerns relating to case-mix and small volume caseloads have 
recently been highlighted in reporting surgeon performance [Walker et al, 2013]. 
 
Based on our findings, we propose that any reporting of practice rates should now be limited 
to data aggregated over several years and may need to consider each cancer site separately. 
However, the substantial effect of random case-mix on observed detection rates, even if GPs 
follow guidelines exactly, mean that alternative approaches are needed. We suggest two ways 
to avoid the influence of case-mix on reported performance. The first is to examine 
specifically whether cancer cases were referred (or not) in accordance with national 
guidelines. The second is to adopt a “confidential enquiry” approach, employing case review 
of designated delayed diagnoses as “never events” [de Wet et al, 2014]. While both require 
more data, and more time to critically reflect on it, they would be more transparent – and 
more likely to lead to constructive changes in practice - than the current crude approach to 
identification of supposedly poorly performing practices. In the meantime, the widespread 
public reporting of GP practice’s use of urgent suspected cancer referral pathways based on 
18 
 
 annual data may be misleading and should be interpreted with caution until a more robust 
reporting methodology is in place.   
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Table 1. Practice, detection and referral characteristics of the two databases 
 
    Northeast Scotland   NHS England 
   Number %   Number % 
Practice List Size (N=77)   (N= 6735)  
<3000 
 
16 20.8 
 
628 9.3 
3001-6000 
 
16 20.8 
 
2121 31.5 
6001-12000 
 
34 44.2 
 
3079 45.7 
>12000 
 
11 14.3 
 
907 13.5 
     
Age standardised annual referral ratio1 
 less than 0.8 
 
30 39.0 
 
1936 28.7 
0.8-1.0 
 
30 39.0 
 
3113 46.2 
more than 1.2 
 
17 22.1 
 
1686 25.0 
       Overall rates2 
 
Mean SD 
 
Mean SD 
Detection rate 
 
0.382 0.098 
 
0.477 0.085 
Conversion rate 0.178 0.058 
 
0.124 0.057 
       Detection rate by number of 
cases 
    25-75 cases 
 
0.361 0.087 
 
0.485 0.085 
76-150 cases 
 
0.353 0.072 
 
0.464 0.073 
151-400 cases   0.389 0.057   0.468 0.064 
 
 
1. The indirectly standardised number of referrals via the Urgent Suspected Cancer pathway relative to a 
practices size and age and sex composition. 
2. Rates for NHS Grampian data include all 7 years (2006-2012). 
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 Table 2. Annual data pooled from all practices to show number of cancers detected by 
different pathways, number of USC referrals and calculated annual detection and 
conversion rates 
 
NHS 
Grampian 
Cancers Referrals Rates (pooled practices)1 
Total2 Urgent (USC)3 Urgent (other)4 USC Detection Conversion 
2006 1133 144 374 1079 0.127 0.133 
2007 1186 167 357 1233 0.141 0.135 
2008 1644 257 605 2097 0.156 0.123 
2009 1667 643 464 3764 0.386 0.171 
2010 1677 919 279 5143 0.548 0.179 
2011 1783 975 320 5904 0.547 0.165 
2012 1525 898 240 6058 0.589 0.148 
       
Pooled 06-12 10615 4003 2639 25278 0.377 0.158 
Pooled 09-12 6639 3435 1303 20774 0.516 0.165 
NHS 
England Total5 Urgent (USC)  USC Detection Conversion 
2010 199317 89027 - 772840 0.447 0.115 
2011 216957 101260 - 907164 0.467 0.112 
2012 229173 109002 - 1007414 0.476 0.108 
2013 235634 114429 - 1120988 0.486 0.102 
Pooled 10-13 881080 413718 - 3808406 0.470 0.109 
 
 
1 These rates are for all patients pooled across practices, they are thus slightly different from the mean 
practice rates shown in table 1 
2 Includes data from all practice-years whether or not any cancer was referred via the USC (Urgent Suspected 
Cancer) pathway 
3 Total number of cancers diagnosed after referral through USC pathway 
4 Total number of cancers diagnosed after referral through other urgent pathway. Prior to 2006 this was the 
only pathway available in NHS Grampian Scotland. This analysis was only available at practice level in Scotland. 
5 Includes data only from practice years in which full data were available (at least 6 cancer cases referred via 
the USC pathway) 
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 Table 3. Correlation coefficients (with 95% confidence intervals) between the Detection Rate 
and Conversion Rate by year and aggregated over all available years for each database  
 
 
  NHS Grampian   NHS England 
Year Coefficient1 95% CI P value   Coefficient1 95% CI P value 
2006 0.18 -0.13 to 0.47 0.21 
 
- - - 
2007 0.28 -0.05 to 0.48 0.05 
 
- - - 
2008 0.13 -0.07 to 0.38 0.32 
 
- - - 
2009 0.28 0.08 to 0.53 0.01 
 
- - - 
2010 0.27 0.06 to 0.44 0.02 
 
0.24 0.21  to 0.26 <0.001 
2011 0.26 0.03 to 0.48 0.03 
 
0.26 0.23 to 0.28 <0.001 
2012 0.08 -0.25 to 0.35 0.48 
 
0.25 0.23 to 0.27 <0.001 
2013 - - - 
 
0.24 0.22 to 0.27 <0.001 
Aggregated 
2006-12 -0.22 -0.41 to 0.08 0.08      
2009-12 -0.16 -0.34 to 0.01 0.12     
2010-13     0.12 0.09 to 0.14 <0.001 
 
 
1 Spearman correlation coefficient with bootstrapped 95% confidence intervals. 
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 Figure 1. Scatter plots of Detection Rate versus Conversion Rate in different years, and 
aggregated across all available years, for each database 
  
  
  
  
Lines indicate linear regression (dotted) and local polynomial regression (solid) 
24 
 
 Northeast Scotland data points (N=77) represent the practice size. 
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 Table 4. Year to year correlation coefficients (95%  confidence interval) for Detection Rate 
and Conversion Rate from GP Practices in England 
Cancer Cases Years Practices Year to year correlation (95% CI)1 
per year     Detection rate Conversion Rate 
 N=6-25 2010 vs.2011 1353 0.21 (0.15 to 0.26) 0.60(0.56 to 0.63) 
2011 vs.2012 1384 0.16 (0.11 to 0.22) 0.60 (0.56 to 0.64) 
2012 vs.2013 1401 0.16 (0.11 to 0.21) 0.60(0.56 to 0.64) 
 N=26-50 2010 vs.2011 2416 0.28 (0.24 to 0.32) 0.48 (0.45 to 0.51) 
2011 vs.2012 2471 0.20 (0.16 to 0.24) 0.52 (0.49 to 0.55) 
2012 vs.2013 2443 0.22 (0.18 to 0.26) 0.53 (0.50 to 0.56) 
 N=51-75 2010 vs.2011 875 0.29 (0.23 to 0.35) 0.55 (0.50 to 0.59) 
2011 vs.2012 1008 0.22 (0.16 to 0.27) 0.50 (0.45 to 0.54) 
2012 vs.2013 1108 0.21 (0.15 to 0.26) 0.52 (0.47 to 0.56) 
 N >75 2010 vs.2011 250 0.33 (0.20 to 0.45) 0.58 (0.48 to 0.67) 
2011 vs.2012 316 0.29(0.19 to 0.39) 0.55 (0.46 to 0.62) 
2012 vs.2013 394 0.35 (0.27to 0.43) 0.63 (0.56 to 0.69) 
All practices 2010 vs.2011 4894 0.26 (0.23 to 0.29) 0.53 (0.51 to 0.55) 
 
2011 vs.2012 5179 0.20 (0.17 to 0.22) 0.54(0.52 to 0.57) 
  2012 vs.2013 5346 0.21 (0.19 to 0.24) 0.55 (0.53 to 0.57) 
     
All NHS 
Grampian 
2006 vs.2007 38 0.26 (-0.07 to 0.55) 0.3 (-0.01 to 0.58)  
2007 vs.2008 41 0.47 (0.2 to 0.66) 0.48 (0.21 to 0.68) 
2008 vs.2009 62 0.25 (-0.01 to 0.42) 0.47 (0.27 to 0.61) 
2009 vs.2010 74 0.28 (0.09 to 0.44) 0.41 (0.16 to 0.61) 
2010 vs.2011 72 -0.01 (-0.24 to 0.21) 0.05 (-0.18 to 0.25) 
2011 vs.2012 73 0.1 (-0.11 to 0.33) 0.2 (-0.01 to 0.39) 
 
 
1 Spearman rank correlation coefficient with bootstrapped 95% confidence intervals 
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Table 5. Results of the modelling of practice Detection Rates with both specified between-
practice variation and random case-mix variation 
Model parameters1 
 
Observed data (detection rate)2 
 
"Poorly performing practices" 
       
Correctly identified3 Total identified4 
 
Cases 
 
SD Min Max 
 
Median IQR Median IQR 
Low 
variation 
(SD = 
0.025) 
25 
 
0.1 0.16 0.8 
 
18 14 to 19 87 80 to 93 
50 
 
0.07 0.24 0.72 
 
19 16 to 21 77 70 to82 
75 
 
0.06 0.27 0.69 
 
24 21 to 27 87 79 to 92 
100 
 
0.06 0.29 0.66 
 
28 24 to 29 87 78 to 94 
150 
 
0.05 0.32 0.64 
 
30 27 to 34 89 84 to 95 
200 
 
0.04 0.34 0.63 
 
35 33 to 38 91 86 to 96 
          
 
Moderate 
variation 
(SD = 
0.05) 
25 
 
0.11 0.12 0.84 
 
20 17 to 24 58 53 to 64 
50 
 
0.09 0.2 0.76 
 
31 28 to 35 77 69 to 89 
75 
 
0.08 0.23 0.73 
 
39 36 to 43 85 78 to 94 
100 
 
0.07 0.25 0.71 
 
44 40 to 47 89 83 to 95 
150 
 
0.06 0.27 0.69 
 
52 48 to 55 91 88 to 95 
200 
 
0.06 0.28 0.68 
 
57 54 to 59 94 89 to 97 
          
 
High 
variation 
(SD = 
0.075) 
25 
 
0.12 0.08 0.88 
 
32 29 to 36 75 70 to 83 
50 
 
0.1 0.14 0.82 
 
44 40 to 48 81 75 to 89 
75 
 
0.09 0.16 0.79 
 
52 49 to 55 90 83 to 95 
100 
 
0.09 0.18 0.77 
 
57 54 to 60 91 86 to 97 
150 
 
0.09 0.2 0.76 
 
64 62 to 67 94 90 to 97 
200   0.08 0.21 0.75   68 66 to 71 95 92 to 98 
 
1 For each set of parameters, 200 sets of 1000 practices were modelled.  
2 Values for SD (standard deviation), minimum and maximum represent median values for all runs of the 
simulation at each specification of practice variation and number of cancer cases. 
3 Correctly identified poorly performing practices represents  the median number (with interquartile range) of 
practices which were in the lowest decile of detection rate before adjusting for case mix (N=100 ) and which 
were also in the lowest decile of detection rate after introducing random case-mix variation.  
4 Total identified poorly performing practices represents the median number (with interquartile range) of 
practices which were in the lowest decile of detection rate after introducing random case-mix variation.  
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